BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Fludase infectious data

NexBio reported data from a single bone marrow transplant patient with PIV-3 infection showing that treatment with DAS181 under emergency-use IND provisions improved the patient's respiratory status within 1 day. By day 3, the patient...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >